- Quarterly
- Annual
- TTM
-
Export .csv
-
Download Image
-
Copy link
-
Embed code
Share URL
Bar Chart preview
Encompass Health Corporation Return on Equity (ROE) is 24.66% for the Trailing 12 Months (TTM) ending March 31, 2025, a 5.11% change year over year. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation. Encompass Health Corporation Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2024 was 23.46%, a 3.87% change year over year. Encompass Health Corporation Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2023 was 22.58%, a 8.01% change year over year. Encompass Health Corporation Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2022 was 20.91%, a 7.28% change year over year. Encompass Health Corporation Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2021 was 19.49%, a -23.10% change year over year.
Embed chart view
From:
To:
Zoom:
- 1Y
- 3Y
- 5Y
- 10Y
- 15Y
- 20Y
- Max